CClinicalTrials.gg
Not yet recruitingNCT07148778Updated Aug 29, 2025

Effectiveness of Chatbot-Supported Web Program in Postpartum Care

An interventional study of Educational intervention in Postpartum Care, Web-based Training and Chatbot-Based Training, sponsored by Emine Ilkin Aydin. Not yet recruiting. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2025-08-29.

Sponsored by Emine Ilkin Aydin · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

The purpose of this clinical study was to evaluate the effectiveness of a web-based "Postpartum Care Package" program developed for postpartum women and delivered via a chatbot, and to examine its effects on the postpartum health of mothers and newborns.

The key questions it aims to answer are:

  • What is the impact of the chatbot-supported web-based "Postpartum Care Package" program on the postpartum health of mothers and newborns?
  • Does the chatbot-supported web-based "Postpartum Care Package" program increase women's accessibility and availability of postpartum care resources?
02

Conditions studied

  • Postpartum Care
  • Web-based Training
  • Chatbot-Based Training

Keywords

  • postpartum care
03

In context

Lead sponsor

This is the only study on the registry with Emine Ilkin Aydin as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: Women who will be included in the study.

  • Have given birth between the 37th and 41st weeks of pregnancy,
  • Be primigravida,
  • Have not been diagnosed with a high-risk pregnancy,
  • Have an educational level of primary school or above,
  • Have no communication difficulties or mental disabilities,
  • Have access to equipment (mobile phone, computer, tablet, internet) for web-based education,
  • Have experienced no complications in the mother or baby during pregnancy, childbirth, or the postpartum period,
  • Voluntarily agree to participate in the study,

Exclusion Criteria:

  • Women who moved outside the province where the study was conducted during the implementation period,
  • Women who voluntarily withdrew from the study,
  • Women who did not participate in any phase of the study will not be included in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
102 participants (estimated)

Study arms

  • Experimental
    Arm 1: Chatbot-Assisted Web-Based Postpartum Care Package Program

    Behavioral: Educational intervention

  • No intervention
    Arm 2: Standard Postpartum Care

Interventions

  • BehavioralEducational intervention

    In this study, a web-based postpartum care package program supported by a chatbot will be administered to the intervention group. A pre-test will be administered to participants in the intervention group within 24-48 hours after birth. Participants in this group will be informed that they must watch the videos in the educational modules until the sixth week postpartum. Reminder messages will also be sent to participants via the website, email, and phone calls (between days 7 and 14 postpartum and week 3 postpartum). Participants who have completed the module training will be eligible for post-tests at 6 weeks postpartum and 3 months postpartum.

06

What researchers measure

Primary outcomes

  1. Postpartum Physical Symptom Severity Scale

    Maternal physical health will be assessed using the Postpartum Physical Symptom Severity Scale. This four-point Likert-type scale ranges from 0 to 54, with higher scores indicating greater severity of postpartum physical symptoms.

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

  2. Visual Analog Scale

    Mothers' physical discomfort/pain levels will be assessed using a Visual Analog Scale. The scale consists of a 10 cm horizontal line, where "0" represents no discomfort and "10" represents the most severe discomfort imaginable. Participants will be asked to mark the point on the line that best reflects their level of physical discomfort/pain during the assessment. Higher scores indicate more severe discomfort/pain.

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

  3. Edinburgh Postpartum Depression Scale

    The Edinburgh Postnatal Depression Scale will be used to screen for depressive symptoms in postpartum women. The scale consists of 10 items on a four-point Likert-type scale. Each item is scored from 0 to 3, and the total score ranges from 0 to 30. Higher scores indicate more depressive symptoms.

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

  4. Sexual Life Quality Scale

    The Sexual Quality of Life Scale will be used to evaluate the impact of sexual functions on the quality of life of individuals. It assesses physical, emotional, and relational aspects of sexual well-being. This Likert-type scale consists of 18 items. Higher scores reflect better sexual quality of life, while lower scores indicate deterioration in sexual well-being.

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

  5. Breastfeeding Self-Efficacy Scale

    The Breastfeeding Self-Efficacy Scale will be used to assess mothers' levels of breastfeeding self-efficacy. It evaluates maternal perceptions regarding their skills, knowledge, and coping abilities related to breastfeeding. The scale consists of 14 items rated on a five-point Likert scale. Scores range from 14 to 70, with higher scores indicating greater breastfeeding self-efficacy.

    Time frame: Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum

Secondary outcomes

  1. Postpartum care package program satisfaction

    Participants' satisfaction level with the Chatbot-supported web-based Postpartum Care Package program will be measured with a 5-point Likert-type satisfaction survey.

    Time frame: 3rd month postpartum

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — There are no plans to share individual participant data (IPD). If data sharing becomes possible in the future, it will be done in accordance with ethical principles and participant confidentiality.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07148778
Lead sponsor
Emine Ilkin Aydin
Responsible party
Emine Ilkin Aydin (Lecturer, Bozok University) — Sponsor-investigator
First posted
Aug 29, 2025
Start date
Oct 1, 2025 (estimated)
Primary completion
Oct 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Aug 29, 2025

Study contacts

Emine ILKIN AYDIN, Lecturer
Contact
emine.ilkin@yobu.edu.tr
+905456281694
Emine ILKIN AYDIN, Lecturer
principal investigator · Yozgat Bozok University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion